SCHEMBL24401347

SCHEMBL24401347

O=c1c2ccccc2sc2cc3c(cc12)C1(c2ccccc2-c2cc(N(c4ccccc4)c4ccc5sc6ccccc6c5c4)ccc21)c1ccccc1-3

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.38
MAPT P10636 5/20 0.37
ALDH1A1 P00352 4/20 0.37
TDP1 Q9NUW8 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
POLB P06746 1/20 0.37
RAB9A P51151 4/20 0.36
NPC1 O15118 3/20 0.36
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
HPGD P15428 3/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
MEN1 O00255 1/20 0.31
HCRTR1 O43613 1/20 0.31
NFKB1 P19838 1/20 0.31
NFKB2 Q00653 1/20 0.31
KMT2A Q03164 1/20 0.31
RELA Q04206 1/20 0.31
CYP1A2 P05177 2/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24401427 0.92 KDM4E (0.39) KDM4EMAPTALDH1A1TDP1L3MBTL1
SCHEMBL19395153 0.90 ALDH1A1 (0.37) KDM4EMAPTALDH1A1TDP1L3MBTL1
SCHEMBL24401655 0.89 ALDH1A1 (0.33) KDM4EMAPTALDH1A1TDP1L3MBTL1
SCHEMBL25563647 0.89 GPR3 (0.36) KDM4EMAPTALDH1A1TDP1L3MBTL1
SCHEMBL25563596 0.88 GPR3 (0.33) KDM4EMAPTALDH1A1TDP1L3MBTL1
SCHEMBL25563532 0.88 GPR3 (0.33) KDM4EMAPTALDH1A1TDP1L3MBTL1
SCHEMBL24401602 0.87 KDM4E (0.39) KDM4EMAPTALDH1A1TDP1L3MBTL1
SCHEMBL19395120 0.86 ALDH1A1 (0.34) MAPTALDH1A1TDP1L3MBTL1POLB
SCHEMBL24401345 0.86 KDM4E (0.35) KDM4EMAPTALDH1A1TDP1L3MBTL1
SCHEMBL24401348 0.86 KDM4E (0.35) KDM4EMAPTALDH1A1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220140249-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2022-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220140249-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CDYL, MRPL38, CDYL2 KDM4E 3526/4885MAPT 3483/4885ALDH1A1 1697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.